Black History Month

Conversation with The Cancer Letter

University of Maryland’s Owonikoko: What it means to be a Black director of an NCI-designated cancer center
Black History MonthConversation with The Cancer Letter

University of Maryland’s Owonikoko: What it means to be a Black director of an NCI-designated cancer center

A month after reporting to work in the top job at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Taofeek K. Owonikoko reflected on the obligations that come with being a Black director of an NCI-designated cancer center.
By Amy Lacey, Otis W. Brawley and Paul Goldberg
Shikha Jain, Shea Holman: It’s time for NIH to be transparent about how misconduct cases are handled
Conversation with The Cancer Letter

Shikha Jain, Shea Holman: It’s time for NIH to be transparent about how misconduct cases are handled

NIH has until Feb. 20 to comply with a congressional subpoena that directs NIH Director Monica Bertagnolli to produce internal documents, including reports and whistleblower complaints that could shed light on whether NIH is adequately responding to complaints of workplace misconduct and sexual harassment. 
By Matthew Bin Han Ong
Prasad could not have had patient data when he called Vanderbilt colleagues “despicable”
Conversation with The Cancer Letter

Prasad could not have had patient data when he called Vanderbilt colleagues “despicable”

Vinay Prasad, a social media phenom and professor of epidemiology and biostatistics at the University of California, San Francisco, recently stunned his colleagues by stating that doctors at Vanderbilt University acted in a “despicable” manner when they offered a double lung transplant to a lung cancer patient. “The doctors at Vanderbilt are despicable in my... […]
By Paul Goldberg
ARPA-H’s Renee Wegrzyn on cancer research: “Think big. Really big. I’m handing you a magic wand.”
Conversation with The Cancer Letter

ARPA-H’s Renee Wegrzyn on cancer research: “Think big. Really big. I’m handing you a magic wand.”

A year ago, Renee Wegrzyn signed up for a very cool job. As the inaugural director of the Advanced Research Projects Agency for Health, she was to prove that the nontraditional, $2.5 billion experiment will yield the kind of high impact its high-risk investment model promises. Since Wegrzyn joined the agency in October 2022, ARPA-H has […]
By Matthew Bin Han Ong